1. |
M. ulceransdisease: antimycobacterials the answer? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
"Pragmatic approach"important in infertility |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
QOL enhanced with formoterol in asthma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
RA: direct medical costs and therapy in Japan, Thailand |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 5-5
L Hunt,
Preview
|
|
摘要:
Rheumatoid arthritis (RA) is one of the most common rheumatic diseases in Japan. The medical costs of care associated with RA are likely to be a function of patients' disability level. A multinational team of researchers assessed the medical costs associated with care among patients with RA and their satisfaction with care, and reported the results at the First Asia-Pacific International Society for Pharmacoeconomics and Outcomes Research conference [Kobe, Japan; September 2003].12Investigators from Thailand presented the results of a study evaluating the pattern of use and costs associated with COX-2 inhibitors.3
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Tramadol beneficial for elderly in long-term care |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Nanoparticle albumin-bound paclitaxel*has higher antitumour activity than polyoxyl 35 castor oil-based paclitaxel |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
FK 778 has vasculoprotective properties |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
GLP-1 agonists: a new approach for type 2 diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 9-10
A Taylor,
Preview
|
|
摘要:
Glucagon-like peptide-1 (GLP-1) is one of the incretin hormones that are released by the enteroendocrine cells of the small intestine in response to food intake. One of the actions of these hormones is to stimulate insulin secretion in the presence of elevated levels of blood glucose. Studies have shown that GLP-1 may also have a range of other actions associated with glucose homeostasis, including regulation of insulin biosynthesis, inhibition of glucagon secretion, modulation of gastrointestinal motility and modulation of food intake. However, it has been shown that there is a deficient GLP-1 response in patients with impaired glucose tolerance or with type 2 diabetes mellitus. A number of studies presented at the 18th International Diabetes Federation (IDF) Congress [Paris, France; August 2003] discussed the effects of GLP-1 and its analogues in type 2 diabetes, and the cellular mechanisms involved in its actions.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
Celecoxib reduces radiation-induced skin damage |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Parathyroid hormone, alendronic acid: no synergy in osteoporosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|